Remikiren

Remikiren

(IUPAC) ime
(2S)-2-[(2R)-2-benzil-3-(2-metilpropan-2-sulfonil)propanamido]-N-[(2R,3S,4R)-1-cikloheksil-4-ciklopropil-3,4-dihidroksibutan-2-il]-3-(1H-imidazol-4-il)propanamid
Klinički podaci
Identifikatori
CAS broj	126222-34-2
ATC kod	C09XA01
PubChem[1][2]	6324659
DrugBank	DB00212
ChemSpider[3]	4884377
UNII	LC7FBL96A4^Y
KEGG[4]	D09038^Y
ChEMBL[5]	CHEMBL31601^Y
Hemijski podaci
Formula	C33H50N4O6S
Mol. masa	630,839 g/mol
SMILES	eMolekuli & PubHem
InChI InChI=1S/C33H50N4O6S/c1-33(2,3)44(42,43)20-25(16-22-10-6-4-7-11-22)31(40)37-28(18-26-19-34-21-35-26)32(41)36-27(17-23-12-8-5-9-13-23)30(39)29(38)24-14-15-24/h4,6-7,10-11,19,21,23-25,27-30,38-39H,5,8-9,12-18,20H2,1-3H3,(H,34,35)(H,36,41)(H,37,40)/t25-,27+,28+,29+,30-/m1/s1^Y Key: UXIGZRQVLGFTOU-VQXQMPIVSA-N^Y
Farmakoinformacioni podaci
Trudnoća	?
Pravni status	Investigacioni

Remikiren je reninski inhibitor koji je u razvoju za tretman hipertenzije (visokog krvnog pritiska). Ovaj lek je razvilo preduzeće Hofman la Roš 1996. godine.^[6]

Reference

1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
4. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
5. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
6. Richter WF, Whitby BR, Chou RC (1996). „Distribution of remikiren, a potent orally active inhibitor of human renin, in laboratory animals”. Xenobiotica 26 (3): 243–54. DOI:10.3109/00498259609046705. PMID 8730917. 

Spoljašnje veze

	Portal Medicina
	Portal Hemija